期刊文献+

脂肪因子Chemerin在产科高危妊娠疾病中的研究进展 被引量:2

Research progress of adipokines Chemerin in high-risk pregnancy diseases of pregnant women
下载PDF
导出
摘要 目的:脂肪组织不仅具有能量储存、保暖等功能,作为人体最大的内分泌器官,还可以通过分泌瘦素、脂联素等多种脂肪因子、细胞间黏附分子-1(ICAM-1)等黏附分子及血管内皮生长因子(VEGF)等参与人体免疫、炎症、脂类代谢、血管生成等。Chemerin是近年来新发现的一种脂肪因子,其可在多种器官及组织中表达,与多种疾病存在相关性。研究发现,Chemerin可参与如妊娠期高血压疾病,妊娠期糖尿病,妊娠合并心脏病、脂肪肝、胰腺炎,甲状腺疾病等产科多种高危妊娠疾病,以及胎儿生长受限,自然流产的发生、发展。本文就脂肪因子Chemerin与产科高危妊娠疾病的相关性作一综述。 Adipose tissue not only has functions of energy storage and heat preservation, but also is the largest endocrine organ of human body, which involves in the human body immunity, inflammation, lipid metabolism, angiogenesis by the secretion of leptin, adiponectin and other fat factor, intercellular adhesion molecule-1 (ICAM-1) such as adhesion molecules, vascular endothelial growth factor (VEGF), and angiogenesis factor. However, Chemerin is a recently discovered adipokines, which can be expressed in many organs and tissues, and it is associated with a variety of diseases. Some studies have found that Chemerin can participate in the occurrence and development of a variety of high-risk pregnancy diseases of pregnant women, such as gestational hypertension, gestational diabetes, gestational heart disease, gestational fatty liver disease, gestational pancreatitis, gestational thyroid disease, gestational fetal growth restriction, and spontaneous abortion. The relationship between adipokines Chemerin and high-risk pregnant diseases is reviewed in this study.
作者 云翠兰 刘惠琴 张志杰 张越美 YUN Cuilan;LIU Huiqin;ZHANG Zhijie;ZHANG Yuemei(Baotou Central Hospital,Baotou,Inner Mongolia Autonomous Region,014040;Inner Mongolia Autonomous Region Baotou City Central Hospital)
出处 《中国计划生育学杂志》 2019年第10期1411-1415,共5页 Chinese Journal of Family Planning
关键词 高危妊娠 脂肪因子类 CHEMERIN Adipokines High-risk pregnancy Chemerin
  • 相关文献

参考文献10

二级参考文献53

  • 1Otto CM. Calcific aortic stenosis-time to look more closely at thevalve[J]. N Engl J Med, 2008, 359(13): 1395-8.
  • 2Muruganandan S, Roman AA, Sinal CJ. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bonemarrow stem cells[J]. J Bone Miner Res, 2010, 25(2): 222-34.
  • 3Gu P, Jiang W, Lu B, et al. Chemerin is associated withinflammatory markers and metabolic syndrome phenotypes inhypertension patients[J]. Clin Exp Hypertens, 2013 Sep 18.[Epubahead of print].
  • 4Bozaoglu K, Segal D, Shields KA, et al. Chemerin is associatedwith metabolic syndrome phenotypes in a Mexican-Americanpopulation[J]. J Clin Endocrinol Metab, 2009, 94(8): 3085-8.
  • 5Expert panel on detection, evaluation, and treatment of high bloodcholesterol in adults. Executive Summary of the Third Report of theNational Cholesterol Education Program (NCEP) Expert panel ondetection, evaluation, and treatment of high blood cholesterol inadults (Adult Treatment Panel III). JAMA, 2001, 285: 2486-97.
  • 6Katz R, Wong ND, Kronmal R, et al. Features of the metabolicsyndrome and diabetes mellitus as predictors of aortic valvecalcification in the Multi-Ethnic Study of Atherosclerosis[J].Circulation, 2006, 113(17): 2113-9.
  • 7Roh SG, Song SH, Choi KC, et al. Chemerin-a new adipokine thatmodulates adipogenesis via its own receptor[J]. Biochem BiophysRes Commun, 2007, 362(4): 1013-8.
  • 8Zabel BA, Allen SJ, Kulig P, et al. Chemerin activation by serineproteases of the coagulation, fibrinolytic, and inflammatorycascades[J]. J Biol Chem, 2005, 280(41): 34661-6.
  • 9Du XY, Zabel BA, Myles T, et al. Regulation of chemerinbioactivity by plasma carboxypeptidase N, carboxypeptidase B(activated thrombin-activable fibrinolysis inhibitor), and platelets[J]. J Biol Chem, 2009, 284(2): 751-8.
  • 10Wittamer V, Grégoire F, Robberecht P, et al. The C-terminalnonapeptide of mature chemerin activates the chemerin receptorwith low nanomolar potency[J]. J Biol Chem, 2004, 279(11):9956-62.

共引文献118

同被引文献24

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部